Intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma

Abstract Purpose Cystic lymphangioma is a common congenital lymphatic malformation. The aim of the study was to compare the safety and efficacy of doxycycline and bleomycin in the treatment of cystic hygroma. Methods A total of 60 children with cystic hygroma were included in the study after fulfill...

Full description

Bibliographic Details
Main Authors: Ashfaque Nabi, K. M. N. Ferdous, Naila Atik Khan, Nazmul Hasan, M. Kabirul Islam
Format: Article
Language:English
Published: SpringerOpen 2022-03-01
Series:Annals of Pediatric Surgery
Subjects:
Online Access:https://doi.org/10.1186/s43159-021-00156-x
_version_ 1819294546880626688
author Ashfaque Nabi
K. M. N. Ferdous
Naila Atik Khan
Nazmul Hasan
M. Kabirul Islam
author_facet Ashfaque Nabi
K. M. N. Ferdous
Naila Atik Khan
Nazmul Hasan
M. Kabirul Islam
author_sort Ashfaque Nabi
collection DOAJ
description Abstract Purpose Cystic lymphangioma is a common congenital lymphatic malformation. The aim of the study was to compare the safety and efficacy of doxycycline and bleomycin in the treatment of cystic hygroma. Methods A total of 60 children with cystic hygroma were included in the study after fulfillment of inclusion and exclusion criteria from July 2016 to June 2018. They were randomly assigned to the doxycycline group (group A = 30 children) or the bleomycin group (group B = 30 children). The comparative parameters between the two groups were the reduction of size of the lesion, adverse effects of both drugs, and treatment cost between groups. All patients were followed up for 6 months. Results Median age was 10.00 months in group A and 8.50 months in group B (p=0.841) Male to female ratio was 1.76:1. There was a significant reduction in the median size of the lesion in both groups after treatment (p<0.001). 86.7% of patients had an excellent response in group A whereas 60% in group B had an excellent response (P=0.049). There was more adverse effect in group B than group A (63.3% vs 36.7%, P=0.04). Conclusion Doxycycline monotherapy had a higher rate of excellent clinical outcomes with fewer side effects than bleomycin and was more cost-effective.
first_indexed 2024-12-24T04:28:03Z
format Article
id doaj.art-9bfdead1db644519b1ed9520065b4db0
institution Directory Open Access Journal
issn 2090-5394
language English
last_indexed 2024-12-24T04:28:03Z
publishDate 2022-03-01
publisher SpringerOpen
record_format Article
series Annals of Pediatric Surgery
spelling doaj.art-9bfdead1db644519b1ed9520065b4db02022-12-21T17:15:30ZengSpringerOpenAnnals of Pediatric Surgery2090-53942022-03-011811610.1186/s43159-021-00156-xIntralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygromaAshfaque Nabi0K. M. N. Ferdous1Naila Atik Khan2Nazmul Hasan3M. Kabirul Islam4Dhaka Medical College HospitalBangladesh Institute of Child Health and Dhaka Shishu HospitalBangabandhu Sheikh Mujib Medical UniversityComilla Medical College HospitalBangladesh Institute of Child Health and Dhaka Shishu HospitalAbstract Purpose Cystic lymphangioma is a common congenital lymphatic malformation. The aim of the study was to compare the safety and efficacy of doxycycline and bleomycin in the treatment of cystic hygroma. Methods A total of 60 children with cystic hygroma were included in the study after fulfillment of inclusion and exclusion criteria from July 2016 to June 2018. They were randomly assigned to the doxycycline group (group A = 30 children) or the bleomycin group (group B = 30 children). The comparative parameters between the two groups were the reduction of size of the lesion, adverse effects of both drugs, and treatment cost between groups. All patients were followed up for 6 months. Results Median age was 10.00 months in group A and 8.50 months in group B (p=0.841) Male to female ratio was 1.76:1. There was a significant reduction in the median size of the lesion in both groups after treatment (p<0.001). 86.7% of patients had an excellent response in group A whereas 60% in group B had an excellent response (P=0.049). There was more adverse effect in group B than group A (63.3% vs 36.7%, P=0.04). Conclusion Doxycycline monotherapy had a higher rate of excellent clinical outcomes with fewer side effects than bleomycin and was more cost-effective.https://doi.org/10.1186/s43159-021-00156-xCystic hygromaDoxycyclineBleomycin hydrochloride
spellingShingle Ashfaque Nabi
K. M. N. Ferdous
Naila Atik Khan
Nazmul Hasan
M. Kabirul Islam
Intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma
Annals of Pediatric Surgery
Cystic hygroma
Doxycycline
Bleomycin hydrochloride
title Intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma
title_full Intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma
title_fullStr Intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma
title_full_unstemmed Intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma
title_short Intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma
title_sort intralesional doxycycline and bleomycin hydrochloride in the treatment of cystic hygroma
topic Cystic hygroma
Doxycycline
Bleomycin hydrochloride
url https://doi.org/10.1186/s43159-021-00156-x
work_keys_str_mv AT ashfaquenabi intralesionaldoxycyclineandbleomycinhydrochlorideinthetreatmentofcystichygroma
AT kmnferdous intralesionaldoxycyclineandbleomycinhydrochlorideinthetreatmentofcystichygroma
AT nailaatikkhan intralesionaldoxycyclineandbleomycinhydrochlorideinthetreatmentofcystichygroma
AT nazmulhasan intralesionaldoxycyclineandbleomycinhydrochlorideinthetreatmentofcystichygroma
AT mkabirulislam intralesionaldoxycyclineandbleomycinhydrochlorideinthetreatmentofcystichygroma